Author/Authors :
Sadeghzadeh Ahari، Jafar نويسنده Gas Research Division, Research Institute of Petroleum Industry (RIPI), Tehran, Iran , , Vakili، Abedin نويسنده , , Bandegi، Ahmad Reza نويسنده Laboratory of Learning and Memory, Research Center and Department of Physiology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran. , , Sameni، Hamid Reza نويسنده Department of Anatomy, School of Medicine, Semnan University of Medical Sciences, Semnan, IR Iran , , Zahedi khorasani، Mahdi نويسنده Research Center and Department of Physiology, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran , , Darabian، Mohsen نويسنده Electrical Engineering Department, University of Zanjan, Zanjan, Iran ,
Abstract :
Objective: Lavender is used in herbal medicine for different therapeutic purposes. Nonetheless,
potential therapeutic effects of this plant in ischemic heart disease and its possible
mechanisms remain to be investigated.
Materials and Methods: In this experimental study, lavender oil at doses of 200, 400
or 800 mg/kg was administered through gastric gavage for 14 days before infarct-like
myocardial injury (MI). The carotid artery and left ventricle were cannulated to record
arterial blood pressure (BP) and cardiac function. At the end of experiment, the heart was
removed and histopathological alteration, oxidative stress biomarkers as well as tumor
necrosis factor-alpha (TNF-?) level were evaluated.
Results: Induction of M.I caused cardiac dysfunction, increased levels of lipid peroxidation,
TNF-? and troponin I in heart tissue (P < 0.001). Pretreatment with lavender oil at
doses of 200 and 400 mg/kg significantly reduced myocardial injury, troponin I and TNF-?.
In addition, it improved cardiac function and antioxidant enzyme activity (P < 0.01).
Conclusion: Our finding showed that lavender oil has cardioprotective effect through inhibiting
oxidative stress and inflammatory pathway in the rat model with infarct-like MI.
We suggest that lavender oil may be helpful in prevention or attenuation of heart injury in
patients with high risk of myocardial infarction and/or ischemic heart disease.